Member Info for Retour_du_Renard

Yeah, like charts are a thing on AIM.

AIM is a sentiment and potential index.

You can move most stocks around with £20 in your pocket here.

This was announced on ASX last early last week.

Not sure why the need to announce an ASX buy on AIM.

Lupuzor smashed their P2 results. Xencor are miles off yet, Maybe 5 years.

NP - Either way the drop is massively over done.

Personally think they need a new fresh and more dynamic face do run their media campaigns as Tim has more than a whiff of Dad's Army about him.

The licenses to research alone are worth more than the current SP.

Personally, I think this is down to a lack of communication skills. Barely communicated with the market for 5 months then suddenly came up with a bewildering RNS that the market was not expecting, backed up with some very dry media output.

They can't seem to explain why the directors are in 'closed period' and have gone quiet about the NDAs.

I think people are starting to suspect that the 10 NDAs could be a load of BS and a convenient cover the the directors not buying in.

Anyone know when the map begins?

Also, any word on the incartha float?

Roz - In correct.

A lot of recent posts have missed a critical point.

Schlumberger and Bakers did a rather intensive assessment on the field and previous OEX drills. OEX have been presented with a report as to how they can re-enter certain wells using new techniques and guidance of stimulation etc.

Therefore, drilling is still on schedule for Q1 2019, pending GSPC result of course.

Things will start moving very quickly from late October.

So when does the MAP officially begin?

Due to broker shenanigans (deliberately maintaining uncompetitively large spreads) who seem to be holding the price down and keeping volume away. We have to ask why? If there is anything here, when then are big pharma (you know, one of the NDAs) are not kicking the door down to snap this up at such a low price. Keep in mind, all other licenses aside, IMM own 16% of a company about to go public!!

I know what you're thinking, 'Ah but they are waiting to see how the MAP pans out'. To that, I say 'Why' ?

Why not buy uber cheap , take the risk and run the MAP yourself with the 500/700p per share you have saved.

Is this stock being held down deliberately by associated brokers in order to get a quick sale.

It certainly seems like it.

sorry NDAs. Lol.

This is clearly the previous broker(s) messing with the spread.

Tim has to generate some noise here. A couple of dry interviews with no real new news isn't go to get people interested again. The closed 'director buy' period is not allowed to be explained according to investor Relations, which many thinking it's going to be the DNAs. Unfortunately, Tim isn't being very forthcoming about those either.

Until the PR department and the new brokers actually get out of bed this price range will be the modus operandi for this stock.

Smith76 - I don't think Tim would give it away for that, not after this was 180 pre P3 results. 50-100p maybe (or anything to keep Leng quiet)

Should be in the 20s at least

SR - As I have said before. the MAP throws the gauntlet down. What could be bought for 50-100p now could cost Big Pharma 700-1000p if the results start coming in and people start posting 'Miracle' videos on youtube etc.

I think this is what Tim has in mind, so we might not have to wait much longer.

It's called a 'Managed Access Programme' for a reason. I'd suggest that they will cherry pick those whose drug history and biological markers will guarantee a better result.

Awesome - Keep talking this down guys. Fantastic average now.

I'd meet Mike on the school run a few times. Lovely chap, cricket fan. Spent many hours chatting and drinking. Must say he looked very rough in the weeks leading up to his departure. Lovely whimsical funeral though.

RIP Mike.

Bob - Did you know Mike Morrison at AJ's?

I can assure you my talk isn't speculative, Get to know the company and the key players before investing in anything and then wait for the price.